Metropolitan Life Insurance Company (MetLife)’s Reata Pharmaceuticals, Inc. Class A Common Stock RETA Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2023
Q3 | – | Sell |
-1,561
| Closed | -$159K | – | 2468 |
|
2023
Q2 | $159K | Buy |
1,561
+66
| +4% | +$6.73K | 0.01% | 782 |
|
2023
Q1 | $136K | Sell |
1,495
-290
| -16% | -$26.4K | 0.01% | 842 |
|
2022
Q4 | $67.8K | Hold |
1,785
| – | – | ﹤0.01% | 1288 |
|
2022
Q3 | $44.9K | Hold |
1,785
| – | – | ﹤0.01% | 1533 |
|
2022
Q2 | $54.2K | Hold |
1,785
| – | – | ﹤0.01% | 1450 |
|
2022
Q1 | $58.5K | Sell |
1,785
-5,754
| -76% | -$189K | ﹤0.01% | 1510 |
|
2021
Q4 | $199K | Hold |
7,539
| – | – | ﹤0.01% | 2032 |
|
2021
Q3 | $758K | Buy |
7,539
+8
| +0.1% | +$805 | 0.01% | 1161 |
|
2021
Q2 | $1.07M | Buy |
7,531
+5,775
| +329% | +$817K | 0.02% | 965 |
|
2021
Q1 | $175K | Buy |
1,756
+74
| +4% | +$7.38K | ﹤0.01% | 2114 |
|
2020
Q4 | $208K | Sell |
1,682
-33
| -2% | -$4.08K | ﹤0.01% | 1913 |
|
2020
Q3 | $167K | Sell |
1,715
-21
| -1% | -$2.05K | ﹤0.01% | 1898 |
|
2020
Q2 | $271K | Sell |
1,736
-5,144
| -75% | -$803K | ﹤0.01% | 1612 |
|
2020
Q1 | $993K | Buy |
6,880
+72
| +1% | +$10.4K | 0.02% | 684 |
|
2019
Q4 | $1.39M | Buy |
6,808
+209
| +3% | +$42.7K | 0.02% | 727 |
|
2019
Q3 | $530K | Buy |
6,599
+419
| +7% | +$33.6K | 0.01% | 1253 |
|
2019
Q2 | $583K | Buy |
6,180
+109
| +2% | +$10.3K | 0.01% | 1213 |
|
2019
Q1 | $519K | Hold |
6,071
| – | – | 0.01% | 1271 |
|
2018
Q4 | $341K | Hold |
6,071
| – | – | 0.01% | 1471 |
|
2018
Q3 | $496K | Buy |
6,071
+611
| +11% | +$50K | 0.01% | 1354 |
|
2018
Q2 | $191K | Buy |
5,460
+1,897
| +53% | +$66.3K | ﹤0.01% | 1972 |
|
2018
Q1 | $73.1K | Hold |
3,563
| – | – | ﹤0.01% | 2407 |
|
2017
Q4 | $101K | Sell |
3,563
-2,929
| -45% | -$83K | ﹤0.01% | 2306 |
|
2017
Q3 | $202K | Hold |
6,492
| – | – | ﹤0.01% | 2265 |
|
2017
Q2 | $205K | Buy |
+6,492
| New | +$205K | ﹤0.01% | 2326 |
|